Abstract:Apocynin, a potent inhibitor of NADPH-oxidase, was widely studied for activities in diseases such as inflammation-mediated disorders, asthma and cardiovascular diseases. In our recent study, a novel nitrone derivative of apocynin, AN-1, demonstrated potent inhibition to oxidative injury and to high expression of gp91(phox) subunit of NADPH-oxidase induced by tert-butyl hydroperoxide (t-BHP) in RAW 264.7 macrophage cells, and displayed promising preclinical protective effect against lipopolysaccharide (LPS)-induced acute lung injury in rats. In this work, the pharmacokinetic behaviors of AN-1 in Sprague-Dawley rats with single intravenous and intragastric doses were investigated for further development. Furthermore, apocynin's pharmacokinetics remain lacking, even though its pharmacological action has been extensively evaluated. The pharmacokinetics of parent apocynin were also comparatively characterized. A simple HPLC method was developed and validated to determine both AN-1 and apocynin in rat plasma. The chromatographic separation was achieved on an Agilent HC-C18 column (250 mmx4.6 mm, 5 mu m) at an isocratic flow rate of 1.0 mL/min, with the mobile phase of methanol and water (53:47, v/v) and the UV detection set at 279 nm. Good linearity was established over the concentration range of 0.1-500 mu g/mL for AN-1 and 0.2-100 mu g/mL for apocynin. The absolute recovery, precision and accuracy were satisfactory. Compared with the parent compound apocynin, AN-1 yielded a much longer T-1/2 (AN-1 179.8 min, apocynin 6.1 min) and higher AUC(0-t) (AN-1 61.89 mmol/L.min, apocynin 2.49 mmol/L.min) after equimolar intravenous dosing (0.302 mmol/kg). The absolute bioavailability of oral AN-1 was 78%, but that of apocynin was only 2.8%. The significant improvement of pharmacokinetic behavior might be accounted for the effective pharmacodynamic results we documented for the novel nitrone derivative AN-1.

Monophosphate Derivatives of Luteolin and Apigenin as Efficient Precursors with Improved Oral Bioavailability in Rats

Comparative biotransformation of luteolin and apigenin from the flower extract and the stem-and-leaf extract of Dendranthema morifolium Ramat. Tzvel. in rats

Preparation and Characterization of Luteolin Nanoparticles for Enhance Bioavailability and Inhibit Liver Microsomal Peroxidation in Rats

Pharmacokinetics, Tissue Distribution and Excretion of Luteolin and Its Major Metabolites in Rats: Metabolites Predominate in Blood, Tissues and Are Mainly Excreted Via Bile

Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies

Nitrogen-Containing Apigenin Analogs: Preparation And Biological Activity

Improved Solubility and Oral Bioavailability of Apigenin Via Soluplus/Pluronic F127 Binary Mixed Micelles System

Preparation, Characterization and Antitumor Activity Evaluation of Apigenin Nanoparticles by the Liquid Antisolvent Precipitation Technique

Enhanced Oral Bioavailability of Acetylpuerarin by Poly(lactide-Co-glycolide) Nanoparticles Optimized Using Uniform Design Combined with Response Surface Methodology

Evaluation of Hepatic Clearance and Drug-Drug Interactions of Luteolin and Apigenin by Using Primary Cultured Rat Hepatocytes

Fabrication of Luteolin Nanoemulsion by Box-Behnken Design to Enhance its Oral Absorption Via Lymphatic Transport

The synthesis and bioactivity of apigenin derivatives

Preparation of Apigenin Nanocrystals Using Supercritical Antisolvent Process for Dissolution and Bioavailability Enhancement.

Complexation of Apigenin and Oxymatrine Leading to Enhanced Anti-inflammatory Activity

Improvement Of Pharmacokinetics Behavior Of Apocynin By Nitrone Derivatization: Comparative Pharmacokinetics Of Nitrone-Apocynin And Its Parent Apocynin In Rats

Pharmacokinetics of apigenin solid lipid nanoparticles in rats

Recent advancement in bioeffect, metabolism, stability, and delivery systems of apigenin, a natural flavonoid compound: challenges and perspectives

Preparation and Evaluation of Puerarin-loaded PLGA Nanoparticles for Improving Oral Bioavailability in SD Rats

Improvements of solubility and bioavailability of lutein through grafting with hydrophilic polyacrylic acid

Optimized Luteolin Loaded Solid Lipid Nanoparticle under Stress Condition for Enhanced Bioavailability in Rat Plasma

The exposure of luteolin is much lower than that of apigenin in oral administration of Flos Chrysanthemi extract to rats.